Attached files

file filename
8-K - 8-K - IMAX CORPd26909d8k.htm

IMAX CORPORATION

Exhibit 99.1

 

LOGO

IMAX CORPORATION

2525 Speakman Drive

Mississauga, Ontario, Canada L5K 1B1

Tel: (905) 403-6500 Fax: (905) 403-6450

www.imax.com

IMAX CORPORATION REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS

HIGHLIGHTS

 

    Record box office of $343 million in Q2 2015 results in over a half a billion of IMAX global box office generated in the first half of the year

 

    Stellar global per screen average of $415 thousand in Q2 2015, driven by a 41% increase in domestic and 33% increase in international per screen averages compared to Q2 2014

 

    Company increases annual installation guidance to 120 new theatres after another above target quarter of 35 new commercial installations in Q2 2015

 

    $107.2 million of revenues in Q2, IMAX’s highest revenue generating quarter ever, was up 35% from same period last year, driving adjusted EPS of $0.40, 60% growth over Q2 2014

NEW YORK, NY – July 23, 2015 – IMAX Corporation (NYSE:IMAX) today reported second quarter 2015 revenues of $107.2 million, adjusted EBITDA as calculated in accordance with the Company’s credit facility of $50.4 million, adjusted net income after non-controlling interest of $28.7 million, or $0.40 per diluted share, and reported net income after non-controlling interest of $24.4 million, or $0.34 per diluted share. The Company also reported a very strong second quarter global per screen average of $414,600.

“The second quarter of 2015 was one of the strongest in IMAX’s history, delivering our highest revenue ever, growing adjusted EPS by 60% compared to the same period last year, record box office and quarterly per screen averages that we have not seen since Avatar in 2010,” stated IMAX CEO Richard L. Gelfond. “We believe the strength of this quarter clearly demonstrates the impact that a strong slate of blockbuster films can have on IMAX and the operating leverage that results.”

Network Growth Update

The total IMAX® theatre network consisted of 976 systems as of June 30, 2015, of which 852 were in commercial multiplexes. There were 391 theatres in backlog as of June 30, 2015, compared to 419 in backlog as of June 30, 2014. In the second quarter of 2015, the Company signed contracts for 30 theatres, of which 28 were for new locations and 2 were for upgrades. In the quarter, the Company also installed 35 theatres, all of which were for new theatre locations. For a breakdown of theatre system signings, installations, network and backlog by type, please see the end of this press release.

“Momentum also continued to build on the network side of our business with higher than expected installations and strong signings activity in the quarter,” continued Gelfond, who is in Vienna for the world premiere of Mission Impossible: Rogue Nation at the historic Vienna Opera House, which has been transformed into an IMAX theatre for this event. “Tonight’s M:I5 event is the continuation of the transformation of IMAX’s brand from the smaller successes onto center stage. More agreements to use IMAX cameras as well as IMAX premieres such as Furious 7 and Jurassic World are a powerful marketer for our brand and also signal the increasingly important role IMAX plays in the entertainment ecosystem.”

 

1


Second-Quarter Segment Results

 

    Revenue from sales and sales-type leases was $18.7 million in the second quarter of 2015, compared to $14.5 million in the second quarter of 2014, primarily reflecting the installation of 15 full theatre systems (14 new, 1 used) under sales and sales-type lease arrangements in the most recent second quarter, compared to the 11 sales-type theatres the Company installed in the prior-year period. In addition, there were no upgrades in existing locations in the second quarter of 2015, compared to 4 xenon upgrades in the second quarter of 2014.

 

    Revenue from joint revenue-sharing arrangements was $31.6 million in the quarter, compared to $19.4 million in the prior-year period. During the quarter, the Company installed 20 new theatres under joint revenue-sharing arrangements, compared to 19 in the same period in 2014. The Company had 477 theatres operating under joint revenue-sharing arrangements as of June 30, 2015, as compared to 408 joint-venture theatres one year prior.

 

    Production and IMAX DMR® (Digital Re-Mastering) revenues were $36.6 million in the second quarter of 2015, compared to $24.0 million in the second quarter of 2014. Gross box office from DMR titles was $343.0 million in the second quarter of 2014, compared to $216.0 million in the prior-year period. The average global DMR box office per screen in the second quarter of 2014 was $414,600 compared to $299,800 in the prior-year period.

Conference Call

The Company will host a conference call today at 8:30 AM ET to discuss its second quarter 2015 financial results. To access the call via telephone, interested parties in the US and Canada should dial (888) 438-5519 approximately 5 to 10 minutes before the call begins. International callers should dial (719) 325-2469. The conference ID for the call is 1711636. A replay of the call will be available via webcast on the ‘Investor Relations’ section of www.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 1711636.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences in extraordinary ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing. As of June 30, 2015, there were 976 IMAX theatres (852 commercial multiplexes, 20 commercial destinations and 104 institutions) in 65 countries.

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

###

This press release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, the signing of theater system agreements; conditions, changes and developments in the commercial exhibition industry; the performance of IMAX DMR films; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company’s growth and operations in China; the Company’s largest customer accounting for a significant portion of the Company’s revenue and backlog; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to the Company’s inability to protect the Company’s intellectual property; risks related to the Company’s implementation of a new enterprise resource planning

 

2


system; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; risks related to the Company’s dependence on a sole supplier for its analog film; risks related to cybersecurity; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

For additional information please contact:

 

Investors:

IMAX Corporation, New York

Teri Loxam

212-821-0100

tloxam@imax.com

 

Business Media:

Sloane & Company, New York

Whit Clay

212-446-1864

wclay@sloanepr.com

Media:

IMAX Corporation, New York

Ann Sommerlath

212-821-0155

asommerlath@imax.com

 

Entertainment Media:

Principal Communications Group, Los
Angeles

Melissa Zuckerman/Paul Pflug

323-658-1555

melissa@pcommgroup.com

paul@pcommgroup.com

 

 

3


Additional Information

Signings and Installations

 

June 30, 2015

 

     Three Months
Ended June 30,
 
Theater Signings:    2015     2014  

Full new sales and sales-type lease arrangements

     19        17   

New joint revenue sharing arrangements

     9        3   
  

 

 

   

 

 

 

Total new theaters

  28      20   

Upgrades of IMAX theater systems

  2  (1)    4  (1)(2) 
  

 

 

   

 

 

 

Total Theater Signings

  30      24   
  

 

 

   

 

 

 

 

     Three Months
Ended June 30,
 
Theater Installations:    2015      2014  

Full new sales and sales-type lease arrangements

     15         11   

New joint revenue sharing arrangements

     20         19   
  

 

 

    

 

 

 

Total new theaters

  35      30   

Upgrades of IMAX theater systems

  —        4  (2) 
  

 

 

    

 

 

 

Total Theater Installations

  35      34   
  

 

 

    

 

 

 

 

     As of June 30,  
Theater Backlog:    2015     2014  

New sales and sales-type lease arrangements

     162        155   

New joint revenue sharing arrangements

     205        242   
  

 

 

   

 

 

 

Total new theaters

  367      397   

Upgrades of IMAX theater systems

  24      22   
  

 

 

   

 

 

 

Total Theaters in Backlog

  391  (3)    419  (3) 
  

 

 

   

 

 

 

 

     As of June 30,  
Theater Network:    2015      2014  

Commercial Multiplex Theaters:

     

Sales and sales-type lease arrangements

     375         327   

Joint revenue sharing arrangements

     477         408   
  

 

 

    

 

 

 

Total Commercial Multiplex Theaters

  852      735   

Commercial Destination Theaters

  20      19   

Institutional Theaters

  104      114   
  

 

 

    

 

 

 

Total IMAX Theater Network

  976      868   
  

 

 

    

 

 

 

 

(1) Includes two signings for the installation of laser-based digital systems in existing theater locations (2014 – 2 signings).
(2) Includes one signing and two installations of upgrades to a xenon-based digital system under short-term operating lease arrangements.
(3) Includes 73 laser theater system configurations (2014 – 66), including upgrades. The Company continues to develop and roll out its laser projection system.

 

4


Additional Information (continued)

 

2015 DMR Films:

In addition to the 23 IMAX DMR films released to the IMAX theater network during the first six months of 2015, 13 additional IMAX DMR films have been announced so far to be released in the remaining six months of 2015:

 

    Monk Comes Down the Mountain: An IMAX 3D Experience (China Film Group, July 2015);

 

    Monster Hunt: An IMAX 3D Experience (Edko Films, July 2015)

 

    Ant-Man: An IMAX 3D Experience (Walt Disney Studios, July 2015);

 

    Pixels: An IMAX 3D Experience (Sony Pictures Entertainment, July 2015);

 

    Mission: Impossible – Rogue Nation: The IMAX Experience (Paramount Pictures, July 2015);

 

    The Man from U.N.C.L.E: The IMAX Experience (Warner Bros. Pictures, August 2015);

 

    Everest: An IMAX 3D Experience (Universal Studios, September 2015);

 

    The Walk: The IMAX Experience (Sony Pictures Entertainment, October 2015);

 

    Crimson Peak: The IMAX Experience (Universal Studios, October 2015);

 

    Spectre : The IMAX Experience (Sony Pictures Entertainment, November 2015);

 

    The Hunger Games: Mockingjay Part 2: An IMAX 3D Experience (Lionsgate, November 2015);

 

    In the Heart of the Sea: The IMAX Experience (Warner Bros. Pictures, December 2015); and

 

    Star Wars: The Force Awakens: An IMAX 3D Experience (Walt Disney Studios, December 2015).

To date, the Company has announced the following 14 titles to be released to the IMAX theater network in 2016:

 

    The Finest Hours: The IMAX Experience (Walt Disney Studios, January 2016);

 

    Warcraft: An IMAX 3D Experience (Universal Studios, March 2016);

 

    Batman v Superman: Dawn of Justice: The IMAX Experience (Warner Bros. Pictures, March 2016);

 

    The Jungle Book: The IMAX Experience (Walt Disney Studios, April 2016);

 

    Captain America: Civil War: The IMAX Experience (Walt Disney Studios, May 2016);

 

    Alice in Wonderland: Through the Looking Glass: The IMAX Experience (Walt Disney Studios, May 2016);

 

    Finding Dory: The IMAX Experience (Walt Disney Studios, June 2016);

 

    Tarzan: The IMAX Experience (Warner Bros. Pictures, July 2016);

 

    Knights of the Roundtable: King Arthur: The IMAX Experience (Warner Bros. Pictures, July 2016);

 

    Suicide Squad: The IMAX Experience (Warner Bros. Pictures, August 2016);

 

    Geostorm: The IMAX Experience (Warner Bros. Pictures, October 2016);

 

    Doctor Strange: An IMAX 3D Experience (Walt Disney Studios, November 2016);

 

    Fantastic Beasts and Where to Find Them: The IMAX Experience (Warner Bros. Pictures, November 2016); and

 

    Rogue One: An IMAX 3D Experience (Walt Disney Studios, December 2016).

The Company remains in active negotiations with all of the major Hollywood studios for additional films to fill out its short and long-term film slate, and anticipates that a similar number of IMAX DMR films will be released to the IMAX network in 2015 to the 40 films that were released to the IMAX network in 2014.

 

5


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)

 

     Three Months
Ended June 30,
    Six Months
Ended June 30,
 
     2015     2014     2015     2014  

Revenues

        

Equipment and product sales

   $ 25,305     $ 19,502     $ 39,741     $ 25,856  

Services

     50,958       39,742       82,674       68,614  

Rentals

     28,527       17,841       42,341       28,632  

Finance income

     2,229       2,060       4,474       4,240  

Other

     141       —         141       —    
  

 

 

   

 

 

   

 

 

   

 

 

 
  107,160     79,145     169,371     127,342  
  

 

 

   

 

 

   

 

 

   

 

 

 

Costs and expenses applicable to revenues

Equipment and product sales

  13,521     9,366     21,061     13,085  

Services

  19,495     17,180     34,302     31,530  

Rentals

  5,109     4,805     8,992     8,525  
  

 

 

   

 

 

   

 

 

   

 

 

 
  38,125     31,351     64,355     53,140  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

  69,035     47,794     105,016     74,202  

Selling, general and administrative expenses (including share-based compensation expense of $5.1 million and $10.7 million for the three and six months ended June 30 2015, respectively (2014 - expense of $4.7 million and $7.9 million, respectively))

  29,023     23,498     57,375     44,810  

Research and development

  2,347     3,309     6,889     6,908  

Amortization of intangibles

  443     416     873     818  

Receivable provisions, net of recoveries

  343     329     348     616  

Impairment of investments

  350     650     350     650  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

  36,529     19,592     39,181     20,400  

Interest income

  259     24     505     40  

Interest expense

  (403   (268   (707   (534
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations before income taxes

  36,385     19,348     38,979     19,906  

Provision for income taxes

  (9,256   (5,407   (9,931   (5,479

Loss from equity-accounted investments, net of tax

  (749   (162   (1,183   (424
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

  26,380     13,779     27,865     14,003  

Net income from discontinued operations, net of tax

  —       —       —       355  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

$ 26,380   $ 13,779   $ 27,865   $ 14,358  

Less: Net income attributable to non-controlling interests

  (2,030   (472   (3,124   (472
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to Common Shareholders

$ 24,350   $ 13,307   $ 24,741   $ 13,886  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share - basic:

Net income per share from continuing operations

$ 0.34   $ 0.19   $ 0.35   $ 0.20  

Net income per share from discontinued operations

  —       —       —       0.01  
  

 

 

   

 

 

   

 

 

   

 

 

 
$ 0.34   $ 0.19   $ 0.35   $ 0.21  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share - diluted:

Net income per share from continuing operations

$ 0.34   $ 0.19   $ 0.34   $ 0.19  

Net income per share from discontinued operations

  —       —       —       0.01  
  

 

 

   

 

 

   

 

 

   

 

 

 
$ 0.34   $ 0.19   $ 0.34   $ 0.20  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding (000’s):

Basic

  69,843     68,228     69,526     68,068  

Fully Diluted

  71,688     69,452     71,349     69,448  

Additional Disclosure:

Depreciation and amortization(1)

$ 11,091   $ 8,390   $ 20,724   $ 15,945  

 

(1) Includes $0.2 million and $0.4 million of amortization of deferred financing costs charged to interest expense for the three and six months ended June 30, 2015, respectively (2014 - $0.1 million and $0.3 million, respectively).

 

6


IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

 

     As at
June 30,
2015
    As at
December 31,
2014
 
     (unaudited)        

Assets

    

Cash and cash equivalents

   $     146,383     $ 106,503  

Accounts receivable, net of allowance for doubtful accounts of $1,222 (December 31, 2014 — $947)

     91,464       76,051  

Financing receivables

     108,492       105,700  

Inventories

     34,186       17,063  

Prepaid expenses

     6,799       4,946  

Film assets

     14,842       15,163  

Property, plant and equipment

     207,099       183,424  

Other assets

     28,342       23,047  

Deferred income taxes

     21,673       23,058  

Other intangible assets

     28,811       27,551  

Goodwill

     39,027       39,027  
  

 

 

   

 

 

 

Total assets

$ 727,118   $ 621,533  
  

 

 

   

 

 

 

Liabilities

Bank indebtedness

$ 22,278   $ 4,710  

Accounts payable

  21,349     26,145  

Accrued and other liabilities

  66,614     75,425  

Deferred revenue

  98,062     88,566  
  

 

 

   

 

 

 

Total liabilities

  208,303     194,846  
  

 

 

   

 

 

 

Commitments and contingencies

Non-controlling interests

  85,532     43,912  
  

 

 

   

 

 

 

Shareholders’ equity

Capital stock, common shares — no par value. Authorized — unlimited number.

70,182,090 — issued and 70,152,426 — outstanding (December 31, 2014 — 68,988,050)

  378,247     344,862  

Less: Treasury stock held in trust, 29,664 shares at cost

  (1,214   —    

Other equity

  42,666     47,319  

Retained earnings (accumulated deficit)

  17,998     (6,259

Accumulated other comprehensive loss

  (4,414   (3,147
  

 

 

   

 

 

 

Total shareholders’ equity

  433,283     382,775  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

$ 727,118   $ 621,533  
  

 

 

   

 

 

 

 

7


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)

 

     Six Months
Ended June 30,
 
     2015     2014  

Cash provided by (used in):

    

Operating Activities

    

Net income

   $ 27,865     $ 14,358  

Net income from discontinued operations

     —         (355

Adjustments to reconcile net income to cash from operations:

    

Depreciation and amortization

     20,724       15,945  

Write-downs, net of recoveries

     1,457       1,579  

Change in deferred income taxes

     2,232       2,789  

Stock and other non-cash compensation

     10,861       8,090  

Unrealized foreign currency exchange loss

     851       64  

Loss from equity-accounted investments

     1,923       574  

Gain on non-cash contribution to equity-accounted investees

     (740     —    

Investment in film assets

     (7,404     (5,147

Changes in other non-cash operating assets and liabilities

     (39,271     (3,219

Net cash provided by operating activities from discontinued operations

     —         572  
  

 

 

   

 

 

 

Net cash provided by operating activities

  18,498     35,250  
  

 

 

   

 

 

 

Investing Activities

Purchase of property, plant and equipment

  (34,920   (16,581

Investment in joint revenue sharing equipment

  (11,613   (10,801

Acquisition of other intangible assets

  (2,972   (970
  

 

 

   

 

 

 

Net cash used in investing activities

  (49,505   (28,352
  

 

 

   

 

 

 

Financing Activities

Issuance of subsidiary shares to a non-controlling interest

  40,000     40,491  

Share issuance costs from the issuance of subsidiary shares to a non-controlling interest

  (2,000   (3,556

Common shares issued - stock options exercised

  22,850     2,657  

Increase in bank indebtedness

  17,568     —    

Credit facility amendment fees paid

  (1,161   —    

Treasury stock purchased for future settlement of restricted share units

  (1,214   —    

Settlement of restricted share units

  (4,988   (790
  

 

 

   

 

 

 

Net cash provided by financing activities

  71,055     38,802  
  

 

 

   

 

 

 

Effects of exchange rate changes on cash

  (168   (159
  

 

 

   

 

 

 

Increase in cash and cash equivalents during the period

  39,880     45,541  

Cash and cash equivalents, beginning of period

  106,503     29,546  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

$ 146,383   $ 75,087  
  

 

 

   

 

 

 

 

8


IMAX CORPORATION

SELECTED FINANCIAL DATA

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment includes the design, manufacture, sale or lease of IMAX theater projection system equipment. The theater system maintenance segment includes the maintenance of IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment includes the provision of IMAX theater projection system equipment to an exhibitor in exchange for a share of the box-office and concession revenues. The film production and IMAX DMR segment includes the production of films and the performance of film re-mastering services. The film distribution segment includes the distribution of films for which the Company has distribution rights. The film post-production segment provides film post-production and film print services. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

 

     Three Months Ended June 30,      Six Months Ended June 30,  
         2015              2014              2015              2014      

Revenue

           

IMAX Theater Systems

           

IMAX Systems

           

Sales and sales-type leases

   $ 18,674      $ 14,478      $ 27,289      $ 18,985  

Ongoing rent, fees, and finance income

     3,691        3,518        7,190        6,771  

Other

     4,674        3,730        8,099        5,242  
  

 

 

    

 

 

    

 

 

    

 

 

 
  27,039     21,726     42,578     30,998  
  

 

 

    

 

 

    

 

 

    

 

 

 

Theater system maintenance

  9,158     8,673     18,008     16,868  
  

 

 

    

 

 

    

 

 

    

 

 

 

Joint revenue sharing arrangements

  31,594     19,363     47,462     30,219  
  

 

 

    

 

 

    

 

 

    

 

 

 

Film

Production and IMAX DMR

  36,603     24,050     54,279     39,235  

Film distribution and post-production

  2,766     5,333     7,044     10,022  
  

 

 

    

 

 

    

 

 

    

 

 

 
  39,369     29,383     61,323     49,257  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ 107,160   $ 79,145   $ 169,371   $ 127,342  
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross margin

IMAX Theater Systems

IMAX systems(1)

Sales and sales-type leases

$ 10,038   $ 8,255   $ 14,945   $ 9,914  

Ongoing rent, fees, and finance income

  3,499     3,334     6,777     6,448  

Other

  (114   454     (154   16  
  

 

 

    

 

 

    

 

 

    

 

 

 
  13,423     12,043     21,568     16,378  
  

 

 

    

 

 

    

 

 

    

 

 

 

Theater system maintenance

  3,089     2,781     6,370     5,782  
  

 

 

    

 

 

    

 

 

    

 

 

 

Joint revenue sharing arrangements(1)

  24,069     13,378     34,686     20,661  
  

 

 

    

 

 

    

 

 

    

 

 

 

Film

Production and IMAX DMR(1)

  28,488     18,634     41,713     29,708  

Film distribution and post-production

  (34   958     679     1,673  
  

 

 

    

 

 

    

 

 

    

 

 

 
  28,454     19,592     42,392     31,381  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ 69,035   $ 47,794   $ 105,016   $ 74,202  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1)

IMAX systems include marketing and commission costs of $0.6 million and $0.9 million for the three and six months ended June 30, 2015, respectively (2014 — $0.7 million and $0.9 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $1.3 million and $1.4 million for the three and six months ended June 30, 2015, respectively (2014 — $1.0 million and $1.2 million, respectively). Production and DMR segment margins include marketing costs of $3.6 million and $4.9 million for the three and six months ended June 30, 2015, respectively (2014 — $2.0 million and $3.2 million, respectively). Distribution segment margins include marketing costs of less than $0.1 million and cost recovery of $0.1 million for the three and six months ended June 30, 2015, respectively (2014 — $0.2 million and $0.4 million, respectively).

 

9


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Non-GAAP Financial Measures:

In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.

The Credit Facility provides that the Company will be required at all times to satisfy a Minimum Liquidity Test (as defined in the Credit Agreement) of at least $50 million. The Company will also be required to maintain minimum EBITDA (as defined in the Credit Agreement) of $90.0 million until December 30, 2015, which requirement increases to $100.0 million on December 31, 2015. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the Credit Agreement) of 2.5:1.0 until December 30, 2015, which requirement decreases to (i) 2.25:1.0 on December 31, 2015; (ii) 2.0:1.0 on December 31, 2016; and (iii) 1.75:1.0 on December 31, 2017. The ratio of total debt to EBITDA was 0.17:1 as at June 30, 2015, where Total Debt (as defined in the Credit Agreement) is the sum of all obligations evidenced by notes, bonds, debentures or similar instruments and was $22.3 million. EBITDA is calculated as follows:

 

     For the
3 months ended
June 30, 2015
     For the
12 months ended
June 30, 2015(1)
 

(In thousands of U.S Dollars)

  

  

Net income

   $ 26,380      $ 55,676   

Add (subtract):

  

  

Loss from equity accounted investments

     749        1,830   

Provision for income taxes

     9,256        18,918   

Interest expense, net of interest income

     144        227   

Depreciation and amortization, including film asset amortization

     10,861        37,876   

Write-downs net of recoveries including asset impairments and receivable provisions

     1,329        5,172   

Stock and other non-cash compensation

     5,195        18,238   

EBITDA attributable to non-controlling interests(2)

     (3,538      (8,519
  

 

 

    

 

 

 
$ 50,376   $ 129,418   
  

 

 

    

 

 

 

 

(1) Ratio of funded debt calculated using twelve months ended EBITDA.
(2)

The EBITDA calculation specified for purposes of the minimum EBITDA covenant excludes the reduction in EBITDA from the Company’s non-controlling interests.

 

10


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended June 30, 2015 vs. 2014:

The Company reported net income of $26.4 million or $0.37 per basic share and $0.36 per diluted share for the second quarter of 2015, as compared to $13.8 million or $0.20 per basic and diluted share for the second quarter of 2014. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $30.7 million or $0.42 per diluted share for the second quarter of 2015 as compared to adjusted net income of $17.7 million or $0.26 per diluted share for the second quarter of 2014. Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation and the related tax impact, was $28.7 million or $0.40 per diluted share for the second quarter of 2015 as compared to adjusted net income attributable to common shareholders of $17.2 million or $0.25 per diluted share for the second quarter of 2014. A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measures, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:

 

     Three Months Ended
June 30, 2015
    Three Months Ended
June 30, 2014
 
     Net Income      Diluted EPS     Net Income      Diluted EPS  

Reported net income

   $ 26,380      $ 0.36  (1)    $ 13,779      $ 0.20  (1) 

Adjustments:

          

Stock-based compensation

     5,103        0.07        4,715        0.07  

Tax impact on items listed above

     (740      (0.01 )       (828      (0.01
  

 

 

    

 

 

   

 

 

    

 

 

 

Adjusted net income

  30,743     0.42  (1)    17,666     0.26  (1) 

Net income attributable to non-controlling interests

  (2,030   (0.02 )     (472   (0.01
  

 

 

    

 

 

   

 

 

    

 

 

 

Adjusted net income attributable to common shareholders

$ 28,713   $ 0.40  (1)  $ 17,194   $ 0.25  (1) 
  

 

 

    

 

 

   

 

 

    

 

 

 

Weighted average diluted shares outstanding

  71,688       69,452  
     

 

 

      

 

 

 

 

(1)

Includes impact of $0.3 million (2014 — $0.1 million) of accretion charges associated with redeemable Class C shares of IMAX China.

 

11


Adjusted Net Income and Adjusted Diluted Per Share Calculations – Six Months Ended June 30, 2015 vs. 2014:

The Company reported net income of $27.9 million or $0.39 per basic share and $0.38 per diluted share for the six months ended June 30, 2015, as compared to $14.4 million or $0.21 per basic and diluted share for the six months ended June 30, 2014. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $36.8 million or $0.51 per diluted share for the six months ended June 30, 2015 as compared to adjusted net income of $20.9 million or $0.30 per diluted share for the six months ended June 30, 2014. Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding stock-based compensation expense and the related tax impact, was $33.7 million, or $0.47 per diluted share, in the six months ended June 30, 2015, as compared to adjusted net income attributable to common shareholders of $20.4 million, or $0.29 per diluted share, for the six months ended June 30, 2014. A reconciliation of net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:

 

     Six Months
Ended June 30, 2015
    Six Months
Ended June 30, 2014
 
     Net Income      Diluted EPS     Net Income      Diluted EPS  

Reported net income

   $ 27,865      $ 0.38  (1)    $ 14,358      $ 0.21  (1) 

Adjustments:

          

Stock-based compensation

     10,678        0.15        7,903        0.11  

Tax impact on items listed above

     (1,702      (0.02     (1,343      (0.02
  

 

 

    

 

 

   

 

 

    

 

 

 

Adjusted net income

  36,841     0.51  (1)    20,918     0.30  (1) 

Net income attributable to non-controlling interests

  (3,124   (0.04   (472   (0.01
  

 

 

    

 

 

   

 

 

    

 

 

 

Adjusted net income attributable to common shareholders

$ 33,717   $ 0.47  (1)  $ 20,446   $ 0.29  (1) 
  

 

 

    

 

 

   

 

 

    

 

 

 

Weighted average diluted shares outstanding

  71,349      69,448  
     

 

 

      

 

 

 

 

(1) Includes impact of $0.5 million (2014 — $0.1 million) of accretion charges associated with redeemable Class C shares of IMAX China.

Free Cash Flow:

Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company’s after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:

 

     For the
6 months ended
June 30, 2015
 
(In thousands of U.S. Dollars)       

Net cash provided by operating activities

   $ 18,498  

Net cash used in investing activities

     (49,505
  

 

 

 

Free cash flow

$ (31,007
  

 

 

 

 

12